nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.05.2013 | Maternal-Fetal Medicine

Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?

verfasst von: Sanjib Kumar Ghosh, Shashi Raheja, Anita Tuli, Chitra Raghunandan, Sneh Agarwal

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine whether maternal serum placental growth factor (PlGF) is more effective as a biomarker in predicting the occurrence of early onset preeclampsia in first trimester or early second trimester of pregnancy.

Methods

A prospective cohort study was conducted on women with singleton pregnancies, screened from the antenatal clinic. Serum PlGF estimation was done at 11–14 weeks of gestation on 1,244 women and at 22–24 weeks of gestation on 1,206 women from the initial study population. A cut-off value of <228 pg/ml for serum PlGF at 11–14 weeks of gestation and <144 pg/ml for serum PlGF at 22–24 weeks of gestation were determined by receiver operating characteristic (ROC) curve analysis for identifying pregnant women at risk of developing early onset preeclampsia (<32 weeks of gestation). Univariate logistic regression analysis was used to analyze the association between serum PlGF < 228 pg/ml at 11–14 weeks of gestation and <144 pg/ml at 22–24 weeks of gestation with the occurrence of early onset preeclampsia and odds ratio (OR) was computed. P value < 0.05 was considered statistically significant in this study.

Results

Maternal serum PlGF <144 pg/ml at 22–24 weeks of gestation had a stronger association (OR 18.83; 95 % CI 12.08–22.24; p = 0.000) than serum PlGF <228 pg/ml at 11–14 weeks of gestation (OR 2.76; 95 % CI 1.29–3.94; p = 0.007) with the occurrence of early onset preeclampsia. The sensitivity and specificity of serum PlGF <144 pg/ml at 22–24 weeks of gestation (84 and 78, respectively) were much higher than those of serum PlGF <228 pg/ml at 11–14 weeks of gestation (58 and 66, respectively) in predicting early onset preeclampsia.

Conclusion

Maternal serum PlGF may be more effective as a biomarker in early second trimester than in first trimester of pregnancy, in predicting the occurrence of early onset preeclampsia.

Pennings JL, Kuc S, Rodenburg W, Koster MP, Schielen PC, de Vries A (2011) Integrative data mining to identify novel candidate serum biomarkers for preeclampsia screening. Prenat Diagn 31(12):1153–1159PubMed

Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC (2011) Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66(4):225–239PubMedCrossRef

Crispi F, Dominguez C, Liurba E, Martin-Gallan P, Cabero L, Gratacos E (2006) Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 195:201–207PubMedCrossRef

Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E (2008) Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 31:303–309PubMedCrossRef

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu K (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683PubMedCrossRef

Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190:1541–1547PubMedCrossRef

Andraweera PH, Dekker GA, Roberts CT (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 18(4):436–457PubMedCrossRef

Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH (2010) Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol 35(6):662–670PubMed

Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E (2010) Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 203(4): 383.e1-8

10.

Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH (2010) First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early onset preeclampsia. BJOG 117(11):1384–1389PubMedCrossRef

11.

Unal ER, Robinson CJ, Johnson DD, Chang EY (2007) Second-trimester angiogenic factors as biomarkers for future onset preeclampsia. Am J Obstet Gynecol 197(2): 211.e1-4

12.

De Vivo A, Baveira G, Giordano D, Todarello G, Corrado F, D’anna R (2008) Endoglin, PlGF and sFlt-1 as markers for predicting preeclampsia. Acta Obstet Gynecol Scand 87(8):837–842PubMedCrossRef

13.

Diab AE, El-Behery MM, Ebraheim MA, Shehata AE (2008) Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 102(2):146–151PubMedCrossRef

14.

Lambert- Messeriian GM, Palomaki GE, Neveux LM, Chien E, Friedman A (2009) Early onset preeclampsia and second trimester serum markers. Prenat Diagn 29(12):1109–1117CrossRef

15.

Mishra D, Singh HP (2003) Kuppuswamy’s socioeconomic status scale—a revision. Indian J Pediatr 70(3):273–274PubMedCrossRef

16.

Davey DA, MacGillivray I (1988) The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892–898PubMed

17.

Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R (2000) Preeclampsia and fetal growth. Obstet Gynecol 96:950–955PubMedCrossRef

18.

MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533–538PubMedCrossRef

19.

Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B (2003) The frequency and severity of placental findings in women with preeclampsia and gestational age dependent. Am J Obstet Gynecol 189:1173–1177PubMedCrossRef

20.

Sebire NJ, Goldin RD, Regan L (2005) Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 25:117–118PubMedCrossRef

21.

Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594PubMedCrossRef

22.

Rasmussen S, Irgens LM (2003) Fetal growth and body proportion in preeclampsia. Obstet Gynecol 101:575–583PubMedCrossRef

23.

Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG (2004) Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 106:377–382CrossRef

24.

Smith GC, Wear H (2009) The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol 21(2):111–116PubMedCrossRef

25.

Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF (2007) Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 196(4):326.e1–326.e13CrossRef

26.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E (2009) A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 22(11):1021–1038PubMedCrossRef

27.

Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate. J Matern Fetal Med 21(1):9–23CrossRef

28.

Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM (2002) Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66:802–812PubMedCrossRef

29.

Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395PubMedCrossRef

30.

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248PubMedCrossRef

31.

Pijnenborg R, Robertson WB, Brosens I, Dixon G (1981) Trophoblast invasion and the establishment of hemochorial placentation in man and laboratory animals. Placenta 2:71–91PubMedCrossRef

32.

Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. BJOG 88:876–881CrossRef

33.

Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29:407–413PubMedCrossRef

34.

Khaliq A, Dun KC, Jiang J, Shams M, Li XF (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor estimation: molecular evidence for “placental hypoxia’ in intrauterine growth restriction. Lab Invest 79(2):151–170PubMed

35.

Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145:4838–4845PubMedCrossRef

36.

Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18:657–665PubMedCrossRef

37.

Gomez O, Figueras F, Martinez JM, Del Rio M, Palacio M, Eixarch E (2006) Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 28:802–808PubMedCrossRef

38.

Kurdi W, Fayyad A, Thakur V, Harrington K (2004) Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon. Eur J Obstet Gynecol Reprod Biol 117:20–23PubMedCrossRef

39.

Hafner E, Schuchter K, Metzenbauer M, Philipp K (2000) Uterine artery Doppler perfusion in the first and second pregnancies. Ultrasound Obstet Gynecol 16:625–629PubMedCrossRef

40.

Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184:1267–1272PubMedCrossRef

41.

Erez O, Romero R, Espinoza J et al (2008) The change in concentrations of angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent of preeclampsia and SGA. J Matern Fetal Neonatal Med 21(5):279–287PubMedCrossRef

42.

Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 24(10):1187–1207PubMedCrossRef

43.

Ness RB, Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365–1370PubMedCrossRef

Titel: Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
verfasst von: Sanjib Kumar Ghosh
Shashi Raheja
Anita Tuli
Chitra Raghunandan
Sneh Agarwal
Publikationsdatum: 01.05.2013
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 5/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-012-2662-2

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2013

A novel therapeutic strategy for chylous ascites after gynecological cancer surgery: a continuous low-pressure drainage system

Relationship between periodontal inflammation and fetal growth in pregnant women: a cross-sectional study

Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia

Sublingual versus vaginal misoprostol for cervical ripening before hysteroscopy: a randomized clinical trial